Related Experiment Video
Updated: May 15, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Stat3 inhibits WTX expression through up-regulation of microRNA-370 in Wilms tumor
Xu Cao1, Dehong Liu, Xiangming Yan
1Department of Surgery, Childrens' Hospital Affiliated to Soochow University, Soochow University, Suzhou 215003, PR China.
Abstract:
Wilms tumor (WT) is a genetically heterogeneous childhood kidney tumor. Several genetic mutations have been identified in WT patients, including inactivation of WTX, somatic stabilizing CTNNB1, and p53 mutations. However, the molecular mechanisms in tumorigenesis remain largely unexplored. Stat3 is a transcription factor that can promote oncogenesis. Stat3 activation is commonly viewed as crucial for multiple tumor proliferation and metastasis. We show that Stat3 is highly activated in Wilms tumor tissues compared to those in adjacent tissues. IL-6 treatment or transfection of a constitutively activated Stat3 in G401 cells promotes cell proliferation. At the molecular level, we further elucidate that Stat3 inhibits WTX expression through up-regulation of microRNA-370. Our results suggest that Stat3/miR-370/WTX regulatory axis might be a critical mechanism in Wilms tumor cells.
Insights
Signal transducer and activator of transcription 3 (Stat3) is highly activated in Wilms tumor. Stat3 promotes Wilms tumor cell proliferation by up-regulating microRNA-370, which inhibits WTX expression.
Area of Science:
- Pediatric oncology
- Molecular biology
- Cancer genetics
Background:
- Wilms tumor (WT) is a heterogeneous childhood kidney cancer with identified genetic mutations.
- The molecular mechanisms driving WT tumorigenesis are not fully understood.
- Signal transducer and activator of transcription 3 (Stat3) is a key transcription factor implicated in oncogenesis.
Purpose of the Study:
- To investigate the role of Stat3 activation in Wilms tumor development.
- To elucidate the molecular mechanisms by which Stat3 influences Wilms tumor progression.
- To identify potential therapeutic targets within the Stat3 signaling pathway.
Main Methods:
- Comparative analysis of Stat3 activation in Wilms tumor tissues versus adjacent tissues.
- In vitro studies using G401 cells treated with IL-6 or transfected with activated Stat3.
- Molecular analysis to determine the effect of Stat3 on WTX expression and microRNA-370 levels.
Main Results:
- Stat3 was found to be highly activated in Wilms tumor tissues.
- IL-6 treatment and activated Stat3 transfection promoted proliferation in G401 cells.
- Stat3 was shown to inhibit WTX expression via up-regulation of microRNA-370.
Conclusions:
- The Stat3/microRNA-370/WTX regulatory axis is a critical mechanism in Wilms tumor pathogenesis.
- Targeting Stat3 activation may offer a therapeutic strategy for Wilms tumor.
- Further research into this pathway could reveal novel insights into childhood kidney cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Canonical Wnt Signaling Pathway
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs
